Development of 68Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography

Nuclear Medicine and Biology

Volumn 38, Issue 3, 2011, Pages 371-379

  Choi, Jae Yeon ^a   Jeong, Jae Min ^a   Yoo, Byong Chul ^b   Kim, Kyunggon ^a   Kim, Youngsoo ^a   Yang, Bo Yeun ^a   Lee, Yun Sang ^a   Lee, Dong Soo ^a   Chung, June Key ^a   Lee, Myung Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Ga 68; Gallium; Lymphoscintigraphy; Mannose; Neomannosyl human serum albumin; NOTA

Indexed keywords

GALLIUM 2 (4 ISOTHIOCYANATOBENZYL) 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID MANNOSYLATED HUMAN SERUM ALBUMIN GA 68; RADIOPHARMACEUTICAL AGENT; SODIUM CARBONATE; UNCLASSIFIED DRUG; 2 (4 ISOTHIOCYANATOBENZYL) 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; 2-(4-ISOTHIOCYANATOBENZYL)-1,4,7-TRIAZACYCLONONANE-1,4,7-TRIACETIC ACID; CHELATING AGENT; DIAGNOSTIC AGENT; GALLIUM; HETEROCYCLIC COMPOUND; ISOTHIOCYANIC ACID DERIVATIVE; MANNOSE; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG LABELING; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; FOOT PAD; LYMPHOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PH; POSITRON EMISSION TOMOGRAPHY; ROOM TEMPERATURE; SENTINEL LYMPH NODE; TEMPERATURE SENSITIVITY; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; LYMPH NODE; METHODOLOGY; PROTEIN CONFORMATION; SCINTISCANNING; SYNTHESIS;

ANIMALS; CHELATING AGENTS; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; HUMANS; ISOTHIOCYANATES; LYMPH NODES; MALE; MANNOSE; MICE; MICE, INBRED ICR; MODELS, MOLECULAR; POSITRON-EMISSION TOMOGRAPHY; PROTEIN CONFORMATION; SERUM ALBUMIN;

EID: 79954414353     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2010.09.010     Document Type: Article

References (46)

1. Mariani G., Moresco L., Viale G., Villa G., Bagnasco M., Canavese G., et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001, 42:1198-1215.
2. Mirzaei S., Rodrigues M., Hoffmann B., Knoll P., Riegler-Keil M., Kreuzer W., et al. Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer. Eur J Nucl Med Mol Imaging 2003, 30:874-878.
3. Pain S.J., Barber R.W., Ballinger J.R., Solanki C.K., O'Mahony S., Mortimer P.S., et al. Side-to-side symmetry of radioprotein transfer from tissue space to systemic vasculature following subcutaneous injection in normal subjects and patients with breast cancer. Eur J Nucl Med Mol Imaging 2003, 30:657-661.
4. Mariani G., Gipponi M., Moresco L., Villa G., Bartolomei M., Mazzarol G., et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med 2002, 43:811-827.
5. Uren R.F., Howman-Giles R., Thompson J.F. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003, 44:570-582.
6. Bartolomei M., Testori A., Chinol M., Gennari R., De Cicco C., Leonardi L., et al. Sentinel node localization in cutaneous melanoma: lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping. Eur J Nucl Med 1998, 25:1489-1494.
7. Stern H.S., McAfee J.G., Subramanian G. Preparation, distribution and utilization of technetium-99m-sulfur colloid. J Nucl Med 1966, 7:665-675.
8. Hung J.C., Wiseman G.A., Wahner H.W., Mullan B.P., Taggart T.R., Dunn W.L. Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy. J Nucl Med 1995, 36:1895-1901.
9. McAfee J.G., Subramanian G., Aburano T., Thomas F.D., Fernandes P., Gagne G., et al. A new formulation of Tc-99m minimicroaggregated albumin for marrow imaging: comparison with other colloids, In-111 and Fe-59. J Nucl Med 1982, 23:21-28.
10. Leidenius M.H., Leppanen E.A., Krogerus L.A., Smitten K.A. The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer. Nucl Med Commun 2004, 25:233-238.
11. Yang S.S., Nickoloff E.L., McIntyre P.A., Maddrey W.C., Mikesell H.H., Scheffel U., et al. Tc-99m human serum albumin: a suitable agent for plasma volume measurements in man. J Nucl Med 1978, 19:804-807.
12. Martindale A.A., Papadimitriou J.M., Turner J.H. Technetium-99m antimony colloid for bone-marrow imaging. J Nucl Med 1980, 21:1035-1041.
13. Seok J.W., Kim I.J. Comparison of the efficiency for Tc-99m tin-colloid and Tc-99m phytate in sentinel node detection in breast cancer patients. Nucl Med Mol Imaging 2008, 42:451-455.
14. Seok J.W., Jun S., Nam H.Y., Kim I.J. Comparison between the 1 day and the 2 day protocols of lymphoscintigraphy and sentinel node biopsy using subareolar injection in breast cancer patients: a retrospective study. Nucl Med Mol Imaging 2009, 43:55-59.
15. Jeong J.M., Hong M.K., Kim Y.J., Lee J., Kang J.H., Lee D.S., et al. Development of 99mTc-neomannosyl human serum albumin (99mTc-MSA) as a novel receptor binding agent for sentinel lymph node imaging. Nucl Med Commun 2004, 25:1211-1217.
16. Henze E., Schelbert H.R., Collins J.D., Najafi A., Barrio J.R., Bennett L.R. Lymphoscintigraphy with Tc-99m-labeled dextran. J Nucl Med 1982, 23:923-929.
17. Jang S.J., Moon S.H., Kim S.K., Kim B.S., Kim S.W., Chung K.W., Lee E.S., et al. Comparison of the results for sentinel lymph node mapping in the breast cancer patients using 99mTc-antimony trisulfide colloid, 99mTc-tin colloid, and 99mTc-human serum albumin. Nucl Med Mol Imaging 2007, 41:546-552.
18. Vera D.R., Wisner E.R., Stadalnik R.C. Sentinel node imaging via a nonparticulate receptor-binding radiotracer. J Nucl Med 1997, 38:530-535.
19. Vera D.R., Wallace A.M., Hoh C.K., Mattrey R.F. A synthetic macromolecule for sentinel node detection: 99mTc-DTPA-mannosyl-dextran. J Nucl Med 2001, 42:951-959.
20. Hoh C.K., Wallace A.M., Vera D.R. Preclinical studies of [99mTc]DTPA-mannosyl-dextran. Nucl Med Biol 2003, 30:457-464.
21. Vera D.R., Wallace A.M., Hoh C.K. [99mTc]MAG3-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection. Nucl Med Biol 2001, 28:493-498.
22. Wallace A.M., Hoh C.K., Vera D.R., Darrah D.D., Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol 2003, 10:531-538.
23. Wallace A.M., Hoh C.K., Ellner S.J., Darrah D.D., Schulteis G., Vera D.R. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol 2007, 14:913-921.
24. He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature 1992, 358:209-215.
25. Kim S., Jeong J.M., Hong M.K., Jang J.J., Lee J., Lee D.S., et al. Differential receptor targeting of liver cells using 99mTc-neoglycosylated human serum albumins. Arch Pharm Res 2008, 31:60-66.
26. Mankoff D.A., Eubank W.B. Current and future use of positron emission tomography (PET) in breast cancer. J Mammary Gland Biol Neoplasia 2006, 11:125-136.
27. Cho Y.S., Choi J.Y., Lee S.J., Hyun S.H., Lee J.Y., Choi Y., Choe Y.S., et al. Clinical significance of focal breast lesions incidentally identified by 18F-FDG PET/CT. Nucl Med Mol Imaging 2008, 42:456-463.
28. Daghighian F., Mazziotta J.C., Hoffman E.J., Shenderov P., Eshaghian B., Siegel S., et al. Intraoperative beta probe: a device for detecting tissue labeled with positron or electron emitting isotopes during surgery. Med Phys 1994, 21:153-157.
29. Strong V.E., Galanis C.J., Riedl C.C., Longo V.A., Daghighian F., Humm J.L., et al. Portable PET probes are a novel tool for intraoperative localization of tumor deposits. Ann Surg Innov Res 2009, 3:2.
30. Essner R., Hsueh E.C., Haigh P.I., Glass E.C., Huynh Y., Daghighian F. Application of an [18F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res 2001, 96:120-126.
31. Ehrhardt G.J., Welch M.J. A new germanium-63/gallium-68 generator. J Nucl Med 1978, 19:925-929.
32. Ambe S. Ge-68-Ga-68 generator with alpha-ferric oxide support. Appl Radiat Isot 1988, 39:49-51.
33. Zhernosekov K.P., Filosofov D.V., Baum R.P., Aschoff P., Bihl H., Razbash A.A., et al. Processing of generator-produced Ga-68 for medical application. J Nucl Med 2007, 48:1741-1748.
34. Studer M., Meares C.F. Synthesis of novel 1,4,7-triazacyclononane-N,N',N'-triacetic acid derivatives suitable for protein labeling. Bioconjug Chem 1992, 3:337-341.
35. Mendez J., Wallace A.M., Hoh C.K., Vera D.R. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs. J Nucl Med 2003, 44:1677-1681.
36. Chipowsky S., Yuan C.L. Synthesis of 1-thioaldosides having an amino group at the aglycon terminal. Carbohydrate Res 1973, 31:339-346.
37. Jeong J.M., Hong M.K., Chang Y.S., Lee Y.S., Kim Y.J., Cheon G.J., et al. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 2008, 49:830-836.
38. Di Stefano G., Tubaro M., Lanza M., Boga C., Fiume L., Traldi P. Synthesis and physicochemical characteristics of a liver-targeted conjugate of fluorodeoxyuridine monophosphate with lactosaminated human albumin. Rapid Commun Mass Spectrom 2003, 17:2503-2507.
39. Parker D. Tumor targeting with radiolabeled macrocycle antibody conjugates. Chem Soc Rev 1990, 19:271-291.
40. Lee J., Garmestani K., Wu C., Brechbiel M.W., Chang H.K., Choi C.W., et al. In vitro and in vivo evaluation of structure-stability relationship of 111In- and 67Ga-labeled antibody via 1B4M or C-NOTA chelates. Nucl Med Biol 1997, 24:225-230.
41. Jeong J.M., Kim Y.J., Lee Y.S., Lee D.S., Chung J.K., Lee M.C. Radiolabeling of NOTA and DOTA with positron emitting 68Ga and investigation of in vitro properties. Nucl Med Mol Imaging 2009, 43:330-336.
42. Clarke E.T., Martell A.E. Stabilities of trivalent metal-ion complexes of the tetraacetate derivatives of 12-membered, 13-membered and 14-membered tetraazamacrocycles. Inorg Chim Acta 1991, 190:37-46.
43. Clarke E.T., Martell A.E. Stabilities of the Fe(Iii), Ga(Iii) and in(Iii) chelates of N,N',N'-triazacyclononanetriacetic acid. Inorg Chim Acta 1991, 181:273-280.
44. Chang Y.S., Jeong J.M., Lee Y.S., Kim H.W., Rai G.B., Lee S.J., et al. Preparation of 18F-human serum albumin: a simple and efficient protein labeling method with 18F using a hydrazone-formation method. Bioconjug Chem 2005, 16:1329-1333.
45. Yang B.Y., Jeong J.M., Kim Y.J., Choi J.Y., Lee Y.S., Lee D.S., et al. Formulation of 68Ga BAPEN kit for myocardial positron emission tomography imaging and biodistribution study. Nucl Med Biol 2010, 37:149-155.
46. Takagi K., Uehara T., Kaneko E., Nakayama M., Koizumi M., Endo K., et al. 99mTc-labeled mannosyl-neoglycoalbumin for sentinel lymph node identification. Nucl Med Biol 2004, 31:893-900.